Very true, and the frustration is understandable. But rules are rules, and that cuts both ways. NWBO is not required to announce an FDA submission unless it chooses to. And based on everything currently available, they have not broken any.
Submitting to the FDA, even under a new program like the Commissioner’s National Priority Voucher, is not automatically considered a material event. The company is allowed to submit confidentially, and unless they selectively disclose that information to someone else, there is no obligation to PR it. That is not “quiet period” spin. It is simply how Regulation FD and SEC reporting rules work.
If the submission is accepted, approved, or otherwise acknowledged in a way the company deems material to shareholders, then they must disclose it. Until then, silence is legally permitted. The same applies to Project Orbis, PIP, and other regulatory channels. These often progress quietly until formal milestones are met.
The company has said, believe nothing until you hear it from us. That applies in both directions. No news is not confirmation or denial. It is just no official news.
Bullish
Market Data 
Markets 
